• 1. Excitonic and vibrational coherence in artificial photosynthetic systems studied by negative-time ultrafast laser spectroscopy
  Dongjia Han,Bing Xue,Juan Du,Tomohiro Miyatake,Hitoshi Tamiaki,Xin Xing,Wei Yuan,Yanyan Li Phys. Chem. Chem. Phys., 2016,18, 24252-24260
• 2. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
• 3. Dissociation of large gaseous serine clusters produces abundant protonated serine octamer
  Jacob S. Jordan,Evan R. Williams Analyst, 2021,146, 2617-2625
• 4. Establishing empirical design rules of nucleic acid templates for the synthesis of silver nanoclusters with tunable photoluminescence and functionalities towards targeted bioimaging applications?
  Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932
• 5. Evidence that the availability of an allylic hydrogen governs the regioselectivity of the Wacker oxidation
  Matthew J. Gaunt,Jinquan Yu,Jonathan B. Spencer Chem. Commun., 2001, 1844-1845

• Solvents and Organic Chemicals Organic Compounds Benzenoids Phenol ethers Phenol ethers
• Solvents and Organic Chemicals Organic Compounds Benzenoids Phenol ethers

Recent Advances in the Application of 2-(Methoxymethoxy)-benzaldehyde (CAS: 5533-04-0) in Chemical Biology and Pharmaceutical Research

2-(Methoxymethoxy)-benzaldehyde (CAS: 5533-04-0) is a versatile chemical intermediate that has garnered significant attention in recent years due to its potential applications in chemical biology and pharmaceutical research. This compound, characterized by its methoxymethoxy-protected benzaldehyde moiety, serves as a key building block in the synthesis of various bioactive molecules. Recent studies have explored its utility in drug discovery, particularly in the development of novel therapeutic agents targeting infectious diseases, cancer, and neurological disorders. The unique reactivity of this compound, combined with its stability under various reaction conditions, makes it an attractive candidate for further investigation.

One of the most notable advancements in the use of 2-(Methoxymethoxy)-benzaldehyde is its incorporation into the synthesis of heterocyclic compounds. Researchers have demonstrated its efficacy in the construction of benzofuran and indole derivatives, which are prominent scaffolds in medicinal chemistry. A 2023 study published in the Journal of Medicinal Chemistry highlighted the compound's role in the development of potent inhibitors of bacterial efflux pumps, a critical mechanism in combating antibiotic resistance. The study reported that derivatives of 2-(Methoxymethoxy)-benzaldehyde exhibited enhanced binding affinity to target proteins, leading to improved antimicrobial activity.

In addition to its applications in antimicrobial drug development, 2-(Methoxymethoxy)-benzaldehyde has shown promise in oncology research. A recent investigation published in Bioorganic & Medicinal Chemistry Letters revealed that this compound could be used to synthesize small-molecule inhibitors of protein-protein interactions involved in cancer cell proliferation. The study utilized computational docking and molecular dynamics simulations to identify optimal structural modifications, resulting in derivatives with significant anti-proliferative effects against breast cancer cell lines. These findings underscore the potential of 2-(Methoxymethoxy)-benzaldehyde as a scaffold for designing next-generation anticancer agents.

Beyond its role in drug discovery, 2-(Methoxymethoxy)-benzaldehyde has also been employed in chemical biology studies aimed at understanding cellular signaling pathways. A 2022 publication in ACS Chemical Biology described the use of this compound as a fluorescent probe for detecting reactive oxygen species (ROS) in live cells. The probe's ability to selectively bind to ROS and emit a measurable signal has provided researchers with a valuable tool for studying oxidative stress-related diseases, such as neurodegenerative disorders and cardiovascular conditions. This application highlights the compound's versatility beyond traditional pharmaceutical uses.

Despite these promising developments, challenges remain in the large-scale production and optimization of 2-(Methoxymethoxy)-benzaldehyde derivatives. Recent efforts have focused on improving synthetic methodologies to enhance yield and purity while reducing environmental impact. A 2023 study in Green Chemistry proposed a solvent-free, catalytic approach to synthesizing this compound, achieving high efficiency and minimal waste generation. Such innovations are critical for ensuring the sustainability of future research and industrial applications involving 2-(Methoxymethoxy)-benzaldehyde.

In conclusion, 2-(Methoxymethoxy)-benzaldehyde (CAS: 5533-04-0) continues to be a valuable asset in chemical biology and pharmaceutical research. Its diverse applications, ranging from antimicrobial and anticancer drug development to chemical probes for cellular studies, demonstrate its broad utility. Ongoing research efforts are expected to further elucidate its potential and address existing limitations, paving the way for novel therapeutic and diagnostic tools. As the field advances, this compound is likely to remain a focal point for innovation in drug discovery and beyond.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)